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Abstract
Background: αA-crystallin (CRYAA/HSPB4), a major component of all vertebrate eye lenses, is
a small heat shock protein responsible for maintaining lens transparency. The R49C mutation in the
αA-crystallin protein is linked with non-syndromic, hereditary human cataracts in a four-generation
Caucasian family.
Methods: This study describes a mouse cataract model generated by insertion of a neomycin-
resistant (neor) gene into an intron of the gene encoding mutant R49C αA-crystallin. Mice carrying
the neor gene and wild-type Cryaa were also generated as controls. Heterozygous knock-in mice
containing one wild type gene and one mutated gene for αA-crystallin (WT/R49Cneo) and
homozygous knock-in mice containing two mutated genes (R49Cneo/R49Cneo) were compared.
Results: By 3 weeks, WT/R49Cneo mice exhibited large vacuoles in the cortical region 100 μm
from the lens surface, and by 3 months posterior and nuclear cataracts had developed. WT/
R49Cneo mice demonstrated severe posterior cataracts at 9 months of age, with considerable
posterior nuclear migration evident in histological sections. R49Cneo/R49Cneo mice demonstrated
nearly complete lens opacities by 5 months of age. In contrast, R49C mice in which the neor gene
was deleted by breeding with CreEIIa mice developed lens abnormalities at birth, suggesting that
the neor gene may suppress expression of mutant R49C αA-crystallin protein.
Conclusion: It is apparent that modification of membrane and cell-cell interactions occurs in the
presence of the αA-crystallin mutation and rapidly leads to lens cell pathology in vivo.
Background
Cataracts involving mutations in lens crystallin genes
have received considerable attention in recent years [1-5].
Vertebrate lens crystallins are divided into two families, α
and βγ. α-crystallin is essential for lens transparency and
accounts for nearly 50% of the protein mass in human
lenses. It is a large multimeric complex with an aggregate
molecular mass of 500,000–1,200,000 Da, and is isolated
from lens fiber cells as a complex of αA- and αB-crystallin
in a 3:1 stoichiometry [6]. αA-crystallin/HSPB4 is a mem-
ber of the small heat shock protein family, which also
includes αB-crystallin/HSPB5 and Hsp27/HSPB1 [7]. The
etiology of lens disease is diverse, but a common patho-
logical endpoint is the formation of large protein aggre-
gates that scatter light. The capacity of α-crystallins to
efficiently trap aggregation-prone denatured proteins is
thought to delay age-related cataract in humans. α-crystal-
lin and homoaggregates of αA and αB-crystallin interact in
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vitro with non-native proteins and prevent their irreversi-
ble aggregation and insolubilization [8]. Using recom-
binant proteins, αA and αB-crystallin have been shown to
interact with many partially denatured substrates. Their
stability, dynamic properties, and ability to transition
from large assemblies to smaller dimeric and monomeric
species appear to be critical for this chaperone ability [9-
13]. The binding of αA and αB-crystallin to misfolded
proteins occurs with a high efficiency [14]; however, once
all the α-crystallin in lens fiber cells has been depleted, the
concentration of irreversibly denatured proteins could
increase, resulting in cataract. αA-crystallin binds to lens
cell membranes and this association is increased in cata-
racts. Indeed, many models of cataract involve alterations
in lens cell membranes [15-17]. The interaction of α-crys-
tallin with the cytoskeleton is also of major importance in
maintaining lens transparency [18-22].
αA-crystallin transcripts are present in mouse lens epithe-
lium at embryonic day 10.5 and continue to be expressed
during embryonic development and postnatally [23].
Studies on α-crystallin knockout mice suggest that loss of
αA-crystallin may increase the concentration of unstable
proteins and affect the solubility of αB-crystallin and γ-
crystallin [24,25]. In addition to its essential role in the
optical and refractive properties of the eye lens, αA-crys-
tallin performs other functions; αA-crystallin knockout
mice exhibit increased lens epithelial cell death and
reduced cell proliferation [26,27], and αA-crystallin is
also expressed in the retina, brain, spleen, and thymus
[28] although its role in these tissues is not fully under-
stood.
Transfection studies show that α-crystallins protect cells
from stress-induced apoptosis [27]. Both αA and αB-crys-
tallin are negative regulators of apoptosis in lens cells
[29,30], and αA-crystallin knockout lens epithelial cells
have a higher level of cell death than wild type cells [31].
Thus, cellular protection by crystallins may delay the
onset of age-related and hereditary cataracts.
Several single-point mutations in α-crystallins have been
linked with hereditary human cataracts [1,32-37]. In αA-
crystallin, R49C and W9X mutations in the N-terminal
domain, and R116C, R116H, and G98R mutations in the
C-terminal domain cause human cataracts, as do C-termi-
nal R120G, 450delA, D140N mutations in αB-crystallin.
Many of these mutations are inherited by autosomal
dominant mechanisms. Study of these αA-crystallin gene
mutations would enhance our understanding of the
mechanisms of cataract formation [1,5,32,34,37-39].
Mutations in αA-crystallin increase the abundance of
aggregation-prone proteins. In vitro studies suggest that
mutant αA-crystallin may aggregate causing increased co-
precipitation of substrate proteins [40-43]. The most com-
mon effect of single-point mutations and truncations is an
increase in the size of the oligomeric complex [44-46].
The R49C mutant of αA-crystallin has a slightly higher
mass and radius of gyration, but the main effect of the
mutation is increased protein insolubility [42]. Arginine is
a highly charged residue, and its replacement by the less
polar cysteine might alter protein assembly and solubility.
Moreover, the positive charge on arginine 49 has been
highly conserved during evolution, and is important for in
vitro chaperone activity of αA-crystallin [47,48].
Several model systems are available to study the effect of
single-point mutations of crystallin genes. Transgenic
mice have been used to investigate the effect of the R116C
mutation in αA-crystallin in vivo [49], and several studies
have used transfected cells expressing mutant proteins
[1,38,50]. Naturally occurring and mutagenesis-induced
mouse models have also been analyzed [51-54]. Naturally
occurring αA-crystallin mutations in mice are Cryaa lop1
(R54H), and Cryaa  R54C mutations in the N-terminal
region, and Y118D and Cryaa Aey7 (V124E) mutations in
the C-terminal domain. While significant information has
been obtained by studying mutant αA-crystallin in vitro,
such studies have certain limitations. Mutations affecting
protein interactions at low concentrations may have little
relevance to how they associate in vivo at higher concen-
trations in the lens. Thus, an optimal model must investi-
gate the effect of the mutation in vivo. To study the
mechanism of hereditary cataracts, this laboratory
recently generated R49C knock-in mice and compared
wild type lenses with heterozygous and homozygous
mutant lenses to investigate gene dosage effects [42,55].
While generating the R49C knock-in mice, in which the
floxed neo cassette was deleted by mating with Cre deletor
mice, we serendipitously created WT/R49Cneo  and
R49Cneo/R49Cneo  mouse cataract models which show
milder lens effects in vivo, thus allowing examination of
the effects of the mutant protein at potentially changed
levels of expression. The aim of the present study was to
characterize the lens abnormalities in WT/R49Cneo and
R49Cneo/R49Cneo mice and compare these with previous
reports of WT/R49C and R49C/R49C lenses [42,55].
Methods
Animals
Mice were maintained at Washington University Division
of Comparative Medicine by trained veterinary staff. All
protocols and animal procedures were approved by the
Washington University Animal Studies Committee. Lens
opacity was monitored by slit lamp biomicroscopy. The
left eye of the animals was examined, and pupils were
dilated with a mixture of 10% phenylephrine hydrochlo-
ride and 1% tropicamide (Alcon, Fort Worth, Texas). Mice
carrying the R49Cneo  locus were generated from one
embryonic stem cell clone (129 background) as previ-BMC Ophthalmology 2009, 9:4 http://www.biomedcentral.com/1471-2415/9/4
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ously described [55]. This locus carries a neomycin cas-
sette flanked by lox P sites inserted into an XhoI site in
intron 1 of Cryaa. One ES clone with the neo insertion but
no Cryaa mutation was used to generate WT/WTneo and
WTneo/WTneo mice. Two lines of mice expressing the muta-
tion in Cryaa, R49CneoKI3 and R49CneoKI4, were bred.
Another mouse line, WTneoKI2, expressing wild type Cryaa
was also generated on 129 background. Mice containing
one copy of the targeted knock-in allele (heterozygous
mice) were interbred to generate homozygous mice. Gen-
otyping primers were used to identify the knock-in con-
struct containing the neomycin cassette as described
previously [55]. Transgenic mice expressing Cre-EIIa on a
C57BL/6 background were bred with homozygous Cryaa
knock-in mice to delete the neor gene. These mice were
described in previous studies [42,55].
Slit lamp examination
Dilated mouse eyes were examined in unanesthetized
mice. Stages of cataracts were defined as follows: Stage 0 –
clear lens; Stage 1 – loss of normal appearance of posterior
lens and prominence of y-suture line; Stage 2 – discrete
posterior changes accompanied by light nuclear opacity;
Stage 3 – nearly mature cataract, involving approximately
three-fourths of the lens with bubbles and opacity; Stage
4 – completely mature cataract involving the cortex with
bubbles and vacuoles.
Histology
For conventional histology, eyes were fixed overnight at
4°C in formalin (Sigma, St. Louis, MO). After a thorough
wash in phosphate-buffered saline, lenses were dehy-
drated through graded acetone and infiltrated in methacr-
ylate resin (H-8100; Technovit, Kulzer, Germany)
according to the following schedule: 1:2 resin:acetone, 1
day; 1:1 resin:acetone, 1 day; 100% resin, 4 days. Blocks
were polymerized for 1 hour at 4°C. Sections (3 μm) were
cut and stained with haematoxylin and eosin.
Immunofluorescence
Immunofluorescence was performed as previously
described [31]. Primary antibody to lens membrane
intrinsic protein MIP was purchased from Alpha Diagnos-
tics International. Alexa568-labeled secondary antibody
(Molecular Probes) was used at 1:500 dilution.
Immunoblotting
Lens extracts were separated into water-soluble and insol-
uble fractions, and examined by SDS-PAGE and immuno-
blotting with an antibody to α-crystallin [56]. Protein
concentration of the water-soluble fractions was deter-
mined by the bicinchoninic acid (BCA) protein assay
according to the manufacturer's instructions (Thermo Sci-
entific-Pierce Chemical Co, Rockford IL). 40–50 μg of
extract was loaded on the gel. The primary antibody was
either a polyclonal antibody (used at 1:500 dilution) to
total α-crystallin or a monoclonal antibody (a gift from
Dr. Paul FitzGerald; used at 1:100 dilution) to αA-crystal-
lin, and horseradish peroxidase-conjugated secondary
antibodies as described previously [27,42,56]. The relative
intensity of the mouse αA-crystallin band at approxi-
mately 20 kDa was analyzed by Image J software. The
decrease in αA-crystallin soluble protein with increasing
numbers of R49Cneor-containing genes was calculated as
the mean of three independent experiments.
Cryoimmuno electron microscopic analysis
Lens sections were examined by cryoimmuno electron
microscopy. Sections (50–80 nm) were treated with a pri-
mary monoclonal antibody to αA-crystallin [27] and anti-
mouse IgG conjugated with 18 nm gold particles as sec-
ondary antibody (Sigma). Specimens were stained with
uranyl acetate and examined in a 1200EX transmission
electron microscope as described previously [57].
Analytical chromatography and analysis
WT/WTneo  and WT/R49Cneo  mouse lenses (1.5 to 2.5
month old) were used to isolate water-soluble proteins
[42]. Six lenses of each genotype were homogenized in
500  μl of phosphate-buffered saline (Sigma) and the
water-soluble protein fraction was separated by centrifu-
gation at 15,000 g. FPLC chromatography was performed
on a chromatography system containing an inline detec-
tor for UV absorption at 280 nm. A 16 cm × 60 cm Super-
dex 200 column (GE Healthcare Biosciences) equilibrated
with 10 mM Tris.Cl; pH 6.8 containing 100 mM NaCl, 1
mM DTT and 0.5 mM EDTA was used. Proteins were
injected at 1 mg/ml for different chromatographic runs.
One ml fractions were collected, and proteins mass was
determined by calibrated molecular mass standards. The
area under each peak was used to determine changes in
abundance of α, β and γ-crystallin fractions. The results
are representative of 6 lenses per genotype. The analysis
was repeated with almost the same results.
Results
While constructing a gene knock-in mouse model of
R49C αA-crystallin, we generated mice carrying a floxed
neor gene in an intron of the Cryaa gene (Figure 1). Mating
these to a mouse expressing Cre recombinase resulted in
removal of the neo cassette, leaving the loxP site adjacent
to exon 1 of the Cryaa gene, and producing a functional
but less active mutant allele [42,55]. Two lines of R49Cneo
mice, R49CneoKI 3 and R49CneoKI 4, were generated from
a single ES cell clone, and the results obtained from these
two lines were very similar. The knock-in mice were viable
and bred normally. Heterozygous WT/R49Cneo mice were
intercrossed to produce R49Cneo/R49Cneo  homozygous
offspring. A control mouse line was also generated from
an ES cell clone that had the neomycin cassette inserted,BMC Ophthalmology 2009, 9:4 http://www.biomedcentral.com/1471-2415/9/4
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but lacked the R49C αA-crystallin mutation. These mice
did not have the altered lens phenotype, and served as a
useful control. We speculated based on previous work by
others [58-60] that the neor gene might exhibit dimin-
ished activity of mutant R49C gene that would provide
novel insights into the biology of R49C αA-crystallin in
vivo. To determine the effect of the R49Cneo gene on α-
crystallin protein expression, lenses were analyzed by gel
permeation chromatography. Figure 2 shows the chroma-
tography profile of water-soluble lens proteins of WT/
WTneo and WT/R49Cneo mice measured by absorbance
measurements at 280 nm. The analysis showed a 30%
decrease in expression of total α-crystallin protein in WT/
R49Cneo heterozygous lens as compared with wild type
lenses. The expression of β-crystallins also decreased
whereas  γ-crystallin expression was not appreciably
affected. As compared with WT/R49C lenses [42], α-crys-
tallin decreased more in the WT/R49Cneo lenses.
Lens opacities were confirmed in R49Cneo mutant mice by
slit lamp analysis (Figure 3). By 3 months, R49Cneo mice
showed evidence of opacities in posterior and nuclear
regions. Over time, the cataract progressed to a nuclear
cataract and then to an all-over opacity that included the
cortical fibers (Figure 3A–D). Heterozygous mice at each
age showed variable lens opacities ranging from clear
(stage 0) at <2 months, stage 0 to stage 2 at 2–3 months,
and clear to complete opacity (stage 4) at >4 months of
age. Wild type mice did not show any of these abnormal-
ities. At least four mice were examined for each genotype
at a given age (Table 1A). The neomycin cassette was
deleted by breeding homozygous R49Cneo mice with Cre-
EIIa transgenic mice. These neomycin-deleted R49C
mutant mice had a more severe lens phenotype, with
homozygous R49C/R49C knock-in neo-deleted mice
exhibiting an opacity that covered three-quarters of the
young lens (Figure 3E and 3F). Overall, cataract progres-
sion was more rapid in R49C/R49C mice than in R49Cneo/
R49Cneo mice.
Examination of αA-crystallin soluble protein revealed that
some of these changes were due to protein insolubility
(Figure 4). Mice with nuclear opacity ranging from stage 1
to stage 3 (by slit lamp analysis) were separated into
water-soluble and insoluble fractions. Water-soluble frac-
Plasmid construct used to generate R49Cneo gene knock-in  mice Figure 1
Plasmid construct used to generate R49Cneo gene 
knock-in mice. The 5' and 3' arms of the αA-crystallin gene 
(Cryaa) were cloned into a vector containing the floxed neo-
mycin (neo) cDNA. Mutagenesis was performed to mutate 
amino acid arginine 49 of αA-crystallin to cysteine (R49C). 
The asterisk above exon 1 indicates the mutation. The num-
bered blue rectangles indicate exons. The filled triangles are 
loxP sites and X denotes the XhoI site. Mouse embryonic 
stem (ES) cells SCC-10 were electroporated with the mutant 
plasmid, and clones testing positive for neo were identified 
and used to generate R49Cneo αA-crystallin knock-in mice 
(WT/R49Cneo). One clone containing wild type (WT) αA-
crystallin cDNA and neo was also analyzed and used to gen-
erate mice with the neo allele but no mutation (WT/WTneo).
FPLC analysis of crystallins in WT/WTneo and WT/R49Cneo  mouse lenses Figure 2
FPLC analysis of crystallins in WT/WTneo and WT/
R49Cneo mouse lenses. UV absorption profile of water-
soluble mouse lens proteins separated from WT/WTneo (red) 
and WT/R49Cneo (blue) by gel permeation chromatography. 
Proteins were pooled from six lenses of each genotype at 
~2-month-old. mAU represents milli absorbance units at 280 
nm.BMC Ophthalmology 2009, 9:4 http://www.biomedcentral.com/1471-2415/9/4
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Lens phenotypes in R49Cneo mice Figure 3
Lens phenotypes in R49Cneo mice. (A-D) Eyes were dilated and examined by slit lamp. (A) Wild type mice (5 months old) 
had clear lenses (stage 0). (B) Heterozygous WT/R49Cneo αA-crystallin knock-in mice (3 months old) had opacity in the poste-
rior and nuclear regions of the lens (stage 2). (C) Homozygous R49Cneo/R49Cneo αA-crystallin knock-in mice (3 months old) 
had a nearly complete cataract (stage 3–4). (D) R49Cneo/R49Cneo αA-crystallin knock-in mouse lenses showed a complete cat-
aract at 5 months (stage 4). (E, F) Cataract in lens of a newborn R49C/R49C homozygous mouse with deletion of the neor gene 
by Cre-recombinase. Slit lamp image (E) shows a severe nuclear opacity at birth (stage 3). (F) Higher magnification of the lens 
shown in (E) shows the nuclear opacity covering ~70% of the lens.
Table 1: Phenotypic changes in wild type (WT), WT/R49Cneo heterozygous, and R49Cneo/R49Cneo homozygous mice.
A. Slit lamp analysis*
Genotype Phenotype Age Group Total
Nuclear and posterior changes by slit lamp biomicroscopy <2 month 2–3 months >4 months
WT 0/4 0/4 2/9 2/17 (0.12)
WT/R49Cneo 3/6 14/22 7/7 24/35 (0.68)
R49Cneo/R49Cneo 4/5 5/7 13/14 22/26 (0.85)
B. Histological analysis*
Genotype Phenotype Age Group Total
Swollen cells and/or posterior changes by histology <1 month 2–3 months >4 months
WT 0/5 1/4 1/7 2/16 (0.13)
WT/R49Cneo 4/11 2/4 2/3 8/18 (0.44)
R49Cneo/R49Cneo 4/5 3/4 6/8 13/17 (0.76)
* For each age group, the total number of mice analyzed is shown in the denominator, and the number of mice demonstrating the phenotype is 
shown in the numerator. The final columns show the total number of mice of each genotype that demonstrate a phenotype, with the proportion 
given in parentheses.BMC Ophthalmology 2009, 9:4 http://www.biomedcentral.com/1471-2415/9/4
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tions were analyzed by immunoblotting. An excess of pro-
tein extract was loaded so that protein would be
detectable even in the homozygous lenses. Protein insol-
ubility was proportional to nuclear cataract formation by
slit lamp analysis.
Examples of the posterior lens changes observed in
R49Cneo αA-crystallin knock-in lens sections are shown in
Figures 5 and 6. Posterior cataract was evident in 3-
month-old R49Cneo/R49Cneo  homozygous mice. At 9
months, WT/R49Cneo heterozygous mouse lenses showed
severe posterior rupture, curling up of the posterior cap-
sule, and migration of cells to the posterior lens
(Figure 6).
At 3 weeks, histological examination of lenses revealed
the presence of both small and large swollen cells or vac-
uoles in the lens cortical fibers of WT/R49Cneo mice,
which were even more evident in R49Cneo homozygous
mouse lenses (Figure 7). Early fiber formation appeared to
occur normally. Swollen fiber cells begin to appear at 3
weeks postnatal in WT/R49Cneo heterozygous mice. Swol-
len fiber cells were confined to a distinct band of cortical
fibers ~100 μm from the lens surface in both young and
old mice. Fiber cells on either side of the swollen fibers
appear to be unaffected. These swollen cells appeared to
Water-soluble αA-crystallin in R49Cneo knock-in lenses Figure 4
Water-soluble αA-crystallin in R49Cneo knock-in 
lenses. Protein solubility was assessed in lenses with differ-
ent nuclear cataract severity ranging from stage 1 to 3 as 
determined by slit lamp analysis. (A) WT lenses had the high-
est protein solubility by immunoblotting with an antibody to 
α-crystallin. The wild type is clear lens (stage 0). A decrease 
in soluble protein levels was seen in the WT/R49Cneo lenses. 
R49Cneo/R49Cneo lenses had a significantly lower water solu-
bility. Proteins were overloaded so that even a small amount 
of protein could be visualized. Under these conditions, cross-
reactivity of the antibody with other crystallins was 
observed. (B) The decrease in levels of soluble proteins was 
determined by densitometric scanning of immunoblots. The 
data represent an average of three independent experiments 
with approximately 3-month-old mouse lenses. Three pairs 
of lenses were analyzed for wild type and R49Cneo/R49Cneo 
homozygous mice. Two pairs of lenses were analyzed for 
WT/R49Cneo heterozygous mice.
Posterior lens defects in R49Cneo knock-in mouse lenses Figure 5
Posterior lens defects in R49Cneo knock-in mouse 
lenses. Lens sections were stained with toluidine blue and 
examined by bright field microscopy. (A) Lens posterior in 3-
month-old wild type mouse appeared normal. (B) Lens poste-
rior of a 3-month-old R49Cneo/R49Cneo homozygous mouse 
showed a ruptured posterior capsule.
Posterior lens defects in R49Cneo knock-in mouse Figure 6
Posterior lens defects in R49Cneo knock-in mouse. 
Images are shown for lens sections from 9.5-month-old WT/
WTneo and WT/R49Cneo mouse. (A) Brightfield image of the 
equatorial region in a WT/WTneo mid-sagittal lens section. (B) 
Brightfield image of the equatorial region in a WT/R49Cneo 
mid-sagittal lens section. (C) Posterior region of a WT/WTneo 
lens shows a normal posterior capsule. (D) A WT/
R49Cneolens with posterior cataract. Note the extensive 
posterior rupture, migration of cells and cell debris (arrow), 
and compaction of the ruptured posterior capsule (arrow-
head).BMC Ophthalmology 2009, 9:4 http://www.biomedcentral.com/1471-2415/9/4
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be formed by membrane rupture and fusion of cytoplas-
mic contents from multiple cells. Extensive undulations
and interdigitations of these membranes as well as large
separations between fiber cells occurred in homozygous
mouse lenses. These gaps are evident in fiber cells that
have detached from the capsule (Figure 6C). The propor-
tion of swollen cells and posterior changes in WT/R49Cneo
and R49Cneo/R49Cneo  mice examined by histology is
shown in Table 1B.
The number of swollen fiber cells increased in lenses of
older homozygous mice, and extended towards the center
of the lens (Figure 8). At 10 months old, a large area of
aberrant fiber cells was observed. Fiber cells near the lens
surface appeared normal. Newly synthesized cortical fib-
ers appeared to form normally, but vacuoles were appar-
ent in a band of fibers in the deep cortex 100 μm from lens
surface, and increased dramatically towards the lens
center.
Immunofluorescence analysis with an antibody to mem-
brane intrinsic protein (MIP) revealed that the swollen
cells are enclosed by fiber cell membranes (Figure 9).
Swollen cells were not found in wild type littermates or in
WTneo mice. Opacification was related to defects in mem-
brane structure of cortical lens fiber cells. Lenses were fur-
ther examined by cryoimmuno electron microscopy with
an antibody to αA-crystallin. Wild type lenses showed
smooth and linear plasma membranes between the fiber
cells, and αA-crystallin was restricted to the cytoplasm
(Figure 10A). In contrast, fiber cell membranes of hetero-
zygous WT/R49Cneo lenses were non-linear with extensive
undulations, and significant gaps between the cells. A
greater proportion of the αA-crystallin immunoreactivity
was associated with fiber cell membranes in the hetero-
zygous lenses (Figure 10B) than in wild type lenses.
Discussion
In human patients with a missense mutation in exon 1 of
the gene encoding αA-crystallin  (CRYAA), autosomal
dominant nuclear cataract was shown to segregate in a
four generation Caucasian family [1]. The C to T transi-
tion in the first base of codon 49 of CRYAA results in the
non-conservative substitution of arginine 49 to cysteine
(R49C) in αA-crystallin protein [1]. Patients with cataracts
are heterozygous for this mutation, which suggests that
both wild type and R49C mutant αA-crystallin subunits
are expressed in these lenses in addition to wild type αB-
crystallin. Unfortunately, photographic documentation of
the cataracts is not available, preventing a detailed pheno-
typic analysis. It was shown previously that the αA-crystal-
lin R49C mutation causes lens opacities in a knock-in
mouse model, due to protein insolubilization and cell
death [42,55]. Here a R49Cneo construct was used that
Morphological alterations in cortical fiber cell membranes of  R49Cneo lenses Figure 7
Morphological alterations in cortical fiber cell mem-
branes of R49Cneo lenses. Lens sections were stained with 
haematoxylin/eosin. (A) Normal appearance of fiber cells in 
the lens equatorial region in 3-week-old wild type lenses. (B) 
Swollen fiber cells and separations between fiber cells in 3-
week-old WT/R49Cneo heterozygous lenses. (C) Gaps 
between fiber cells in 3-week-old R49Cneo/R49Cneo 
homozygous lenses.BMC Ophthalmology 2009, 9:4 http://www.biomedcentral.com/1471-2415/9/4
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causes a milder lens phenotype to show that R49C αA-
crystallin disrupts normal fiber cell organization and
structure.
Homozygous mice with deletion of the floxed neor gene
(R49C/R49C) have a more drastic phenotype, with
smaller eyes and smaller lenses than wild type and heter-
ozygous (WT/R49C) mutant mice [55]. This implies that
the neor gene is suppressing expression of the R49C-αA
mutant protein, and is supported by FPLC analysis of sol-
uble lens proteins. Indeed, previous studies indicate that
selectable markers inserted in non-coding regions can
affect gene expression at both the DNA and RNA level,
resulting in reduced protein expression [58-60].
The lenses of WT/R49Cneo and R49Cneo/R49Cneo mice dis-
played remarkable posterior lens defects and accumula-
tion of swollen cells in the lens cortex, and developed
nuclear cataracts. Both posterior lens cell defects and
number of swollen fiber cells increased with age and with
R49Cneo dosage, with more defects in R49Cneo/R49Cneo
mice than in WT/R49Cneo mice. The appearance of swol-
len fiber cells in the lens cortex may be an early marker of
structural perturbation in the R49Cneo lenses. The swollen
fiber cells in deep cortical fibers of R49Cneo lenses were
evident as early as 3 weeks postnatal and increased with
age, such that more than half of the lens was covered with
swollen fiber cells at 10 months.
Histological and immunofluorescence analysis of the
R49Cneo knock-in lenses suggests that the lens opacities
observed in R49Cneo mice are associated with membrane
defects in the deep cortical fiber cells approximately 100
μm from the lens surface that result in gaps between adja-
cent fiber cells. Visible swelling or vacuolar areas are often
limited to one or more segments of a fiber cell; hence it is
likely that there are many more aberrant fiber cells than
those observed in a single mid-sagittal section. Vacuolated
cells indicate destruction of the fiber cells. Further studies
are necessary to determine whether these vacuolar or
swollen cells are formed by membrane rupture and fusion
of cytoplasmic contents from multiple cells. This type of
fiber cell swelling has been reported in diabetic and other
models of cataract [61,62]. Membrane defects have also
been shown to be associated with lens opacities induced
by dexamethasone and mechanical stress in cultured
lenses, both of which are associated with the loss of cad-
herin junctions [17,63]. The interaction between αA-crys-
tallin and fiber cell membranes is well-established
[16,64,65], and has been shown to increase with lens
Morphological alterations in lenses from older wild type and R49Cneo/R49Cneo knock-in mice Figure 8
Morphological alterations in lenses from older wild type and R49Cneo/R49Cneo knock-in mice. (A) Lens from wild 
type 10-month-old mouse with normal fiber cells near the lens surface and normal appearing fibers. (B) Large swollen cells and 
gaps between fiber cells in lens from 10-month-old R49Cneo/R49Cneo mouse. (C) The swollen fiber cells increased in both size 
and number with increased age, and extended towards the center of the lens. The number of swollen cells per lens section is 
shown.
Immunofluorescence analysis of fiber cells in wild type and  R49Cneo/R49Cneo knock-in lenses Figure 9
Immunofluorescence analysis of fiber cells in wild 
type and R49Cneo/R49Cneo knock-in lenses. Immunoflu-
orescence staining of lens sections with an antibody to mem-
brane intrinsic protein MIP and an Alexa568-conjugated 
secondary antibody (red) revealed a normal fiber cell mor-
phology in wild type lenses (A), whereas the R49Cneo/
R49Cneo lenses (B) showed disorganized fiber cells and swol-
len cells (arrows) enclosed by membranes. Nuclei are shown 
by arrowheads.BMC Ophthalmology 2009, 9:4 http://www.biomedcentral.com/1471-2415/9/4
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aging and in cataracts [66]. In the current study, mem-
brane alterations in WT/R49Cneo mouse lenses were con-
firmed by ultrastructural analysis. Cryoimmuno electron
microscopic analysis of heterozygous R49Cneo lenses with
an antibody specific to αA-crystallin showed loss of mem-
brane linearity in the cortical fiber cells, undulations of
the membranes, and significant gaps between cells. Fur-
thermore, more αA-crystallin was membrane-associated
in the heterozygous knock-in lens fiber cells than in the
wild type controls. Our studies also showed that the solu-
bility of αA-crystallin is decreased in the R49Cneo lenses,
which may have a profound effect on its binding to lens
fiber cell membranes [67].
Evidence in the literature suggests that loss of α-crystallin
function through gene knockout or mutation alters pro-
tein homeostasis by increasing the abundance of aggrega-
tion-prone proteins. This may result in altered protein-
protein interactions, and protein insolubility [55,68].
Correct protein conformation is essential for normal cell
function, and proteotoxic stress due to protein aggrega-
tion and loss of protein homeostasis is known to be asso-
ciated with aging and disease [69].
In the present work, no significant defects were found in
WT/WTneo and WTneo/WTneo lenses. In targeted gene dele-
tion studies in mice, αA+/- heterozygous mouse lenses do
not show lens opacification, whereas αA-/- homozygous
lenses develop cataracts at an early age [24]. Most of the
defects in αA-crystallin knockout (αA-/-) mouse lenses are
due to protein insolubility in the lens nucleus and cell
death in the lens epithelium [24,31]; no defects in fiber
cell elongation or fiber cell morphology were reported.
Our previous study showed that lens defects in R49C/
R49C knock-in mice are the result of a drastic alteration of
lens fiber cell morphology, although early fiber cell elon-
gation is normal [55]. In the present study, we did not
observe as strong an effect on lens fiber morphology in
young R49Cneo mice as in R49C/R49C mice, but did
observe varied posterior lens defects beginning at an early
postnatal age, as well as posterior migration of nuclei at
older ages and posterior rupture. Such posterior migration
of epithelial cells has been reported in human posterior
subcapsular cataracts [70,71]. A disorganization of the
postequatorial fiber zone was also observed, which has
been reported in human posterior subcapsular cataracts.
Thus, the R49Cneo mouse model system appears to be an
effective model for human posterior subcapsular cata-
racts.
Conclusion
In summary, the results of the present work, combined
with previously published data, provide evidence that αA-
crystallin plays a role in the structure of fiber cell mem-
branes, and is involved in the formation of hereditary cat-
aracts. The present study provides insight into the in vivo
effects of the R49C mutation of αA-crystallin on the lens,
and extends the findings of previous studies [1,42]. In
mice, expression of the R49C αA-crystallin mutant pro-
tein in the presence of the neor gene causes posterior cata-
racts with posterior migration of epithelial cell nuclei, and
demonstrates that the mutant protein affects the integrity
of lens fiber cells in the deep cortex. These changes are
milder than those observed when the neor gene is deleted.
By studying homozygous R49Cneo/R49Cneo  mice that
begin to lose transparency around 2 months of age, com-
pared with the typical onset at birth in R49C/R49C mice,
the author has obtained additional information about the
progression of cataracts. The R49Cneo mice described in
the present study are one of only a few models available
Cryoimmuno electron microscopic analysis of wild type and  R49Cneo/R49Cneo knock-in lenses Figure 10
Cryoimmuno electron microscopic analysis of wild 
type and R49Cneo/R49Cneo knock-in lenses. Lenses 
expressing either wild type or heterozygous R49Cneo/
R49Cneo αA-crystallin were labeled with an antibody to αA-
crystallin and analyzed by cryoimmuno electron microscopy. 
(A) Wild type lenses showed linear fiber cell membranes. 
Immunogold labeling (black dots) showed that αA-crystallin 
was restricted to the cytoplasm. (B) Heterozygous WT/
R49Cneo αA-crystallin lenses had several gold particles on the 
fiber cell membranes. Furthermore, the linearity of lens fiber 
cell membranes was lost, and significant gaps between cells 
were apparent.BMC Ophthalmology 2009, 9:4 http://www.biomedcentral.com/1471-2415/9/4
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to study hereditary posterior cataract, a common human
lens pathology.
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